SREBP‐1c is phosphorylated by activated AMPK, resulting in decreased proteolytic cleavage of the protein, inhibition of nuclear translocation, and ultimately amelioration of hepatic steatosis 12. This evidence concerns the gene SREBF1 and fatty liver disease.